Target intelligence / Profile preview

Caseinolytic mitochondrial matrix peptidase chaperone subunit X (CLPX)

Target
CLPX
Molecular classification
Enzyme, AAA+ ATPase (ATPases Associated with diverse cellular Activities), Protein unfoldase, Chaperone
01

Overview

Caseinolytic mitochondrial matrix peptidase chaperone subunit X (CLPX) is a mitochondrial AAA+ ATPase enzyme and protein unfoldase that is an essential component of the ClpXP proteolytic complex. CLPX recognizes, unfolds, and translocates misfolded, damaged, or regulatory protein substrates into ClpP for degradation, playing a key role in mitochondrial protein quality control and cell stress responses[2][3]. In addition to degradation, CLPX in mitochondria can remodel target proteins in a non-proteolytic manner to regulate biosynthetic enzyme activation (such as activation of 5-aminolevulinate synthase for heme biosynthesis)[1]. Dysregulation of CLPX function is implicated in diseases related to mitochondrial dysfunction, neurodegeneration, aging, and certain cancers. CLPX recognizes substrates via phosphorylation marks, most notably phosphorylated serine residues, and is essential for mitochondrial health and viability in several biological contexts[2][3].

Other names
ATP-dependent clpX-like chaperone, mitochondrialATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrialClpX caseinolytic peptidase X homologClpX caseinolytic protease X homologEnergy-dependent regulator of proteolysisEPP2
02

Mechanism of action

Proteolysis: Recognition, unfolding, and translocation of substrate proteins into ClpP, leading to their degradation[2][3]. Non-proteolytic unfolding: CLPX can remodel substrates for activation (e.g., facilitating cofactor incorporation into ALAS for heme biosynthesis)[1]. Small molecule allosteric modulation (e.g., ONC201 alters selectivity by activating ClpP)[2]

03

Biological functions

Protein quality controlProtein degradation (with ClpP)Protein unfoldingRegulation of mitochondrial enzyme activityStress responseCellular homeostasisMitochondrial biosynthetic enzyme activation (e.g., activation of 5-aminolevulinate synthase for heme biosynthesis)
04

Disease associations

Cancer (necessary for survival of some cancer cells, implicated in targeting acute myeloid leukemia)Neurodegenerative disease (loss of function linked to mitochondrial dysfunction and proteostasis failure)AgingFertility and embryogenesis (defects in CLPX/CLPXP can cause fertility loss and early embryonic death in animal studies)Infection (potential target for overcoming antibiotic resistance in bacteria)
05

Safety considerations

Disruption of mitochondrial protein quality control and homeostasis may lead to toxicity, especially in tissues dependent on high mitochondrial functionPotential impact on fertility, neural aging, and embryogenesis in organismal studiesRisk of triggering mitochondrial dysfunction if protein degradation is dysregulated or excessive
06

Interacting drugs

ONC201 (small molecule that hyperactivates ClpP, impacts substrate selectivity of the CLPX–CLPP complex)
07

Biomarkers

Protein aggregates with phosphorylated serine (pSer) residues that are selectively found among mitochondrial CLPX substratesNo established clinical biomarkers for patient selection or monitoring specifically for CLPX yet

Beyond the preview

Go deeper on Caseinolytic mitochondrial matrix peptidase chaperone subunit X (CLPX).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Caseinolytic mitochondrial matrix peptidase chaperone subunit X (CLPX).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call